NCT01222611View on ClinicalTrials.gov

HCV Evolution in HIV/HCV (Genotype 1) Coinfected Patients Treated With Fosamprenavir

PHASE4CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Chronic HIV InfectionHCV Coinfection
Interventions
DRUG

Fosamprenavir

HAART including fosamprenavir boosted with ritonavir

Trial Locations (6)

28007

Hospital Gregorio Marañón, Madrid

28046

Hospital La Paz, Madrid

Unknown

Hospital Príncipe de Asturias, Alcalá de Henares

Hospital Clínico San Carlos, Madrid

Hospital Doce de Octubre, Madrid

Hospital Ramón y Cajal, Madrid

Sponsors

Collaborators (1)

ViiV Healthcare
All Listed Sponsors
collaborator

ViiV Healthcare

INDUSTRY

lead

Fundacion SEIMC-GESIDA

OTHER